logo-loader
Circassia Pharmaceuticals PLC

Circassia's AirNOvent drug a step closer to market with FDA pre-submission meeting

Circassia Pharmaceuticals PLC (LON:CIR) CEO Steve Harris tells Proactive London's Andrew Scott their partner, AIT Therapeutics Inc. has successfully completed a pre-submission meeting with the US FDA for the ventilator-compatible nitric oxide product AirNOvent.

AIT anticipates submitting a Premarket Approval application (PMA) for AirNOvent in the second quarter of 2019 for use in the treatment of hypoxic respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN).

Circassia intends launching the product in the first half of 2020, once approved.

Quick facts: Circassia Pharmaceuticals PLC

Price: £0.18

Market: LSE
Market Cap: £67.16 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Circassia Pharmaceuticals PLC named herein, including the promotion by the Company of Circassia Pharmaceuticals PLC in any Content on the Site,...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Sarama Resources is well funded with an interesting project...

Sarama Resources (CVE: SWA) CEO Andrew Dinning sat down with Steve Darling from Proactive Vancouver to discuss the company and its' 100% owned South Houndé Project which is located situated in the prolific Houndé Belt. Dinning talked about the work that has been done there in the past and...

4 hours, 18 minutes ago

RNS

Holding(s) in Company

7 hours, 34 minutes ago

Holding(s) in Company

1 day, 7 hours ago

Holding(s) in Company

1 day, 7 hours ago

Holding(s) in Company

2 days, 12 hours ago

Holding(s) in Company

2 days, 13 hours ago

Holding(s) in Company

3 days, 8 hours ago

Block listing Interim Review

6 days, 7 hours ago

2 min read